NCT05854303 Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
| NCT ID | NCT05854303 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Opioid-Induced Esophageal Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 26 participants |
| Start Date | 2023-09-18 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 26 participants in total. It began in 2023-09-18 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).
Eligibility Criteria
Inclusion Criteria: \- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms. Exclusion Criteria: * Inability to provide informed consent. * Patients with previous gastroesophageal surgery or pneumatic dilation. * Esophageal botulinum toxin injection within the prior 12 months. * Esophageal stricture * Achalasia types I and II * Allergy to Lidocaine or other local anesthetics * Subjects on anticoagulation * Bilateral nasal obstruction * Pregnancy or breast feeding
Contact & Investigator
Diana Snyder, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05854303 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid-Induced Esophageal Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05854303 currently recruiting?
Yes, NCT05854303 is actively recruiting participants. Contact the research team at robran.mariah@mayo.edu for enrollment information.
Where is the NCT05854303 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05854303 clinical trial?
NCT05854303 is sponsored by Mayo Clinic. The principal investigator is Diana Snyder, MD at Mayo Clinic. The trial plans to enroll 26 participants.